Severe Malaria: North American Perspective

  • Monica E. Parise
  • Linda S. Lewis
Part of the Perspective on Critical Care Infectious Diseases book series (CCID, volume 9)


Antimalarial Drug Disseminate Intravascular Coagulation Falciparum Malaria Severe Malaria Cerebral Malaria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    WHO, Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg, 2000. 94Suppl 1:p. S1–90.Google Scholar
  2. 2.
    Health information for the international traveler 2003–2004. Centers for Disease Control and Prevention. 2003, Atlanta: US Department of Health and Human Services, Public Health Service.Google Scholar
  3. 3.
    Singhasivanon, P., Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Southeast Asian J Trop Med Public Health, 1999. 30Suppl 4: p. i–iv, 1–101.PubMedGoogle Scholar
  4. 4.
    Lobel, H.O., C.C. Campbell, and J.M. Roberts, Fatal malaria in US civilians. Lancet, 1985. 1(8433): p. 873.PubMedGoogle Scholar
  5. 5.
    Greenberg, A.E. and H.O. Lobel, Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med, 1990. 113(4): p. 326–7.PubMedGoogle Scholar
  6. 6.
    Rowe, J.A., et al., Short report: Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates. Am J Trop Med Hyg, 2002. 66(5): p. 458–60.PubMedGoogle Scholar
  7. 7.
    MacPherson, G.G., et al., Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol, 1985. 119(3): p. 385–401.PubMedGoogle Scholar
  8. 8.
    Miller, L.H., et al., The pathogenic basis of malaria. Nature, 2002. 415(6872): p. 673–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Greenwood, B.M., et al., Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg, 1987. 81(3): p. 478–86.PubMedCrossRefGoogle Scholar
  10. 10.
    Moore, D.A., et al., Assessing the severity of malaria. Bmj, 2003. 326(7393): p. 808–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Freedman, D.O., Imported malaria—here to stay. Am J Med, 1992. 93(3): p. 239–42.PubMedCrossRefGoogle Scholar
  12. 12.
    Brabin, B.J. and Y. Ganley, Imported malaria in children in the UK. Arch Dis Child, 1997. 77(1): p. 76–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Molyneux, M.E., et al., Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med, 1989. 71(265): p. 441–59.PubMedGoogle Scholar
  14. 14.
    Zucker, J. and C.C. Campbell, Malaria: Principles of Prevention and Treatment, in Parasitic Diseases. 1993. p. 547–567.Google Scholar
  15. 15.
    White, N.J., The treatment of malaria. N Engl J Med, 1996. 335(11): p. 800–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Kyriacou, D.N., et al., Emergency department presentation and misdiagnosis of imported falciparum malaria. Ann Emerg Med, 1996. 27(6): p. 696–9.PubMedGoogle Scholar
  17. 17.
    Kain, K.C., et al., Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis, 1998. 27(1): p. 142–9.PubMedGoogle Scholar
  18. 18.
    White, N.J., S. Krishna, and S. Looareesuwan, Encephalitis, not cerebral malaria, is likely cause of coma with negative blood smears. J Infect Dis, 1992.166(5): p. 1195–6.PubMedGoogle Scholar
  19. 19.
    Chia, J.K., M.M. Nakata, and S. Co, Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon. J Infect Dis, 1992. 165(3): p. 599–600.PubMedGoogle Scholar
  20. 20.
    Zucker, J.R. and C.C. Campbell, Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon. J Infect Dis, 1992. 166(6): p. 1458–9.PubMedGoogle Scholar
  21. 21.
    Availability and use of parenteral quinidine gluconate for severe or complicated malaria. MMWR Morb Mortal Wkly Rep, 2000. 49(50): p. 1138–40.Google Scholar
  22. 22.
    Miller, K.D., A.E. Greenberg, and C.C. Campbell, Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med, 1989. 321(2): p. 65–70.PubMedCrossRefGoogle Scholar
  23. 23.
    Product Information: Quinidine Gluconate Injection: Uses and Dosage. 2001, Medscape Inc.Google Scholar
  24. 24.
    Pukrittayakamee, S., et al., Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg, 1994. 88(3): p. 324–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Briggs, G.G., R.K. Freeman, and S.J. Yaffe, Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th ed. 2002, Philadelphia: Williams & Wilkins.Google Scholar
  26. 26.
    Looareesuwan, S., et al., Quinine and severe falciparum malaria in late pregnancy. Lancet, 1985. 2(8445): p. 4–8.PubMedGoogle Scholar
  27. 27.
    McGready, R., et al., Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg, 2001. 95(6): p. 651–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Pukrittayakamee, S., et al., Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob Agents Chemother, 2000. 44(9): p. 2395–8.PubMedCrossRefGoogle Scholar
  29. 29.
    White, N.J., et al., Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. Am J Med, 1982. 73(4): p. 564–72.PubMedCrossRefGoogle Scholar
  30. 30.
    Availability and Use of Parenteral Quinidine Gluconate for Severe or Complicated Malaria. MMWR Morb Mortal Wkly Rep, 2000. 49(50): p. 1138–40.Google Scholar
  31. 31.
    Warrell, D.A., et al., Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med, 1982. 306(6): p. 313–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Hoffman, S.L., et al., High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis, 1988. 158(2): p. 325–31.PubMedGoogle Scholar
  33. 33.
    White, N.J., Not much progress in treatment of cerebral malaria. Lancet, 1998. 352(9128): p. 594–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Smith, H.J. and M. Meremikwu, Iron chelating agents for treating malaria. Cochrane Database Syst Rev, 2003(2): p. CD001474.Google Scholar
  35. 35.
    Looareesuwan, S., et al., Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature. Q J Med, 1990. 75(277): p. 471–81.PubMedGoogle Scholar
  36. 36.
    Hoontrakoon, S. and Y. Suputtamongkol, Exchange transfusion as an adjunct to the treatment of severe falciparum malaria. Trop Med Int Health, 1998. 3(2): p. 156–61.PubMedCrossRefGoogle Scholar
  37. 37.
    Saddler, M., et al., Treatment of Severe Malaria by Exchange Transfusion. N Engl J Med, 1990: p. 58.Google Scholar
  38. 38.
    Mordmuller, B. and P.G. Kremsner, Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Clin Infect Dis, 1998. 26(4): p. 850–2.PubMedGoogle Scholar
  39. 39.
    Marik, P.E., Severe falciparum malaria: survival without exchange transfusion. Am J Trop Med Flyg, 1989. 41(6): p. 627–9.Google Scholar
  40. 40.
    Burchard, G.D., et al., Exchange blood transfusion in severe falciparum malaria: retrospective evaluation of 61 patients treated with, compared to 63 patients treated without, exchange transfusion. Trop Med Int Health, 1997. 2(8): p. 733–40.PubMedCrossRefGoogle Scholar
  41. 41.
    Riddle, M.S., et al., Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis, 2002. 34(9): p. 1192–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Powell, V.I. and K. Grima, Exchange transfusion for malaria and babesia infection. Transfus Med Rev, 2002. 16(3): p. 239–50.PubMedCrossRefGoogle Scholar
  43. 43.
    Mainwaring, C.J., et al., Automated exchange transfusion for life-threatening plasmodium falciparum malaria—lessons relating to prophylaxis and treatment. J Infect, 1999. 39(3): p. 231–3.PubMedCrossRefGoogle Scholar
  44. 44.
    Macallan, D.C., et al., Red cell exchange, erythrocytapheresis, in the treatment of malaria with high parasitaemia in returning travellers. Trans R Soc Trop Med Hyg, 2000. 94(4): p. 353–6.PubMedCrossRefGoogle Scholar
  45. 45.
    Files, J.C., C.J. Case, and F.S. Morrison, Automated erythrocyte exchange in fulminant falciparum malaria. Ann Intern Med, 1984. 100(3): p. 396.PubMedGoogle Scholar
  46. 46.
    Sighinolfi, L., et al., Treatment of cerebral malaria by erythrocyte exchange. Recenti Prog Med, 1990. 81(12): p. 804–5.PubMedGoogle Scholar
  47. 47.
    Zhang, Y., et al., Erythrocytapheresis for Plasmodium falciparum infection complicated by cerebral malaria and hyperparasitemia. J Clin Apheresis, 2001. 16(1): p. 15–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. 2003, WHO: Geneva.Google Scholar
  49. 49.
    Davis, T.M., et al., Calcium and phosphate metabolism in acute falciparum malaria. Clin Sci (Colch), 1991. 81(3): p. 297–304.Google Scholar
  50. 50.
    Adrogue, H.J. and N.E. Madias, Management of life-threatening acid-base disorders. First of two parts. N Engl J Med, 1998. 338(1): p. 26–34.PubMedCrossRefGoogle Scholar
  51. 51.
    Marino, P., The ICU Book. 2nd ed, ed. S.R. Zinner. 1998, Baltimore: Williams & Wilkins.Google Scholar
  52. 52.
    Stacpoole, P.W., et al., A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med, 1992. 327(22): p. 1564–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Krishna, S., et al., Dichloroacetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment. Metabolism, 1994. 43(8): p. 974–81.PubMedCrossRefGoogle Scholar
  54. 54.
    Agbenyega, T., et al., Glucose and lactate kinetics in children with severe malaria. J Clin Endocrinol Metab, 2000. 85(4): p. 1569–76.PubMedCrossRefGoogle Scholar
  55. 55.
    White, N., Controversies in the management of severe falciparum malaria. Balliere’s Clinical Infectious Diseases, 1995. 2: p. 309–330.Google Scholar
  56. 56.
    Trang, T.T., et al., Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis, 1992. 15(5): p. 874–80.PubMedGoogle Scholar
  57. 57.
    Newton, C.R., T.T. Hien, and N. White, Cerebral malaria. J Neurol Neurosurg Psychiatry, 2000. 69(4): p. 433–41.PubMedCrossRefGoogle Scholar
  58. 58.
    Warrell, D.A., Cerebral malaria: clinical features, pathophysiology and treatment. Ann Trop Med Parasitol, 1997. 91(7): p. 875–84.PubMedCrossRefGoogle Scholar
  59. 59.
    Crawley, J., et al., Seizures and status epilepticus in childhood cerebral malaria. Qjm, 1996. 89(8): p. 591–7.PubMedGoogle Scholar
  60. 60.
    Crawley, J., et al., Electroencephalographic and clinical features of cerebral malaria. Arch Dis Child, 2001. 84(3): p. 247–53.PubMedCrossRefGoogle Scholar
  61. 61.
    Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. Jama, 1993. 270(7): p. 854–9.Google Scholar
  62. 62.
    White, N.J., et al., Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet, 1988. 2(8602): p. 64–6.PubMedGoogle Scholar
  63. 63.
    Crawley, J., et al., Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet, 2000. 355(9205): p. 701–6.PubMedCrossRefGoogle Scholar
  64. 64.
    Meremikwu, M. and A.G. Marson, Routine anticonvulsants for treating cerebral malaria. Cochrane Database Syst Rev, 2002(2): p. CD002152.Google Scholar
  65. 65.
    White, N.J., et al., Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med, 1983. 309(2): p. 61–6.PubMedCrossRefGoogle Scholar
  66. 66.
    White, N.J., et al., Hypoglycaemia in African children with severe malaria. Lancet, 1987. 1(8535): p. 708–11.PubMedGoogle Scholar
  67. 67.
    Kwiatkowski, D., Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. JExp Med, 1989. 169(1): p. 357–61.Google Scholar
  68. 68.
    Kwiatkowski, D., Tumour necrosis factor, fever and fatality in falciparum malaria. Immunol Lett, 1990. 25(1-3): p. 213–6.PubMedCrossRefGoogle Scholar
  69. 69.
    Meremikwu, M., K. Logan, and P. Garner, Antipyretic measures for treating fever in malaria. Cochrane Database Syst Rev, 2000(2): p. CD002151.Google Scholar
  70. 70.
    Menendez, C., A.F. Fleming, and P.L. Alonso, Malaria-related anaemia. Parasitology Today, 2000. 16(11): p. 469–76.PubMedCrossRefGoogle Scholar
  71. 71.
    Phillips, R.E., et al., The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med, 1986. 58(227): p. 305–23.PubMedGoogle Scholar
  72. 72.
    Butler, T., et al., Blood coagulation studies in Plasmodium falciparum malaria. Am J Med Sci, 1973. 265(1): p. 63–7.PubMedGoogle Scholar
  73. 73.
    Stone, W.J., J.E. Hanchett, and J.H. Knepshield, Acute renal insufficiency due to falciparum malaria. Review of 42 cases. Arch Intern Med, 1972. 129(4): p. 620–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Punyagupta, S., et al., Acute pulmonary insufficiency in falciparum malaria: summary of 12 cases with evidence of disseminated intravascular coagulation. Am J Trop Med Hyg, 1974. 23(4): p. 551–9.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Monica E. Parise
    • 1
  • Linda S. Lewis
    • 2
  1. 1.Centers for Disease Control and PreventionAtlantaUSA
  2. 2.Health Studies ConsultingMedfordUSA

Personalised recommendations